| Name | Title | Contact Details |
|---|
Leading Research into Solving one of the World`s Largest Drivers of Disease: Inflammation
Rubedo Life Sciences is an anti-aging company based in the Silicon Valley, California.
BioPorto s flagship product, The NGAL Test™, aids in the risk assessment of AKI in critically ill patients. CE marked for IVD use in select regions.
Process Environments is a League City, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Millendo Therapeutics is focused on developing novel treatments for endocrine diseases. Our mission is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of diseases where there is a significant unmet medical need. We are currently advancing two product candidates: livoletide (AZP-531) and nevanimibe (ATR-101). Livoletide is being developed for Prader-Willi syndrome while nevanimibe is in development for the treatment of two different orphan adrenal diseases: Classic Congenital Adrenal Hyperplasia (CAH) and Endogenous Cushing`s Syndrome (CS).